K. Gillies

Symptom Burden and Outcomes of Patients With Platinum Resistant/Refractory Recurrent Ovarian Cancer: A Reality Check

M. Stockler, A. Oza, P. Butow, 2014, International Journal of Gynecologic Cancer.

Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.

M. Stockler, A. Oza, P. Butow, 2013, The oncologist.

Development of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit With Chemotherapy for Symptomatic Ovarian Cancer

M. Stockler, A. Oza, P. Butow, 2014, International Journal of Gynecologic Cancer.

PARAGON: Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynecologic neoplasms: ANZGOG 0903.

M. Stockler, V. Gebski, P. Beale, 2013 .

Double-blind randomized multicenter study comparing Maalox TC tablets and ranitidine in healing of duodenal ulcers

J. Hunter, K. Gillies, J. Crowe, 1991, Digestive Diseases and Sciences.